According to a report from National Nurses United, 81.6 percent of nurses said they experienced workplace violence in 2023.

Ask any healthcare worker, and they will have their own story of workplace violence. In the early years of my career, I narrowly missed encountering a gunman in the hospital ER solely because I forgot something and had to return upstairs. While tragedy was avoided in my case, too often, it is not. Such incidents are not isolated; in fact, they are becoming disturbingly common.

According to a report from National Nurses United, 81.6 percent of nurses said they experienced workplace violence in 2023.

As a physician, providing excellent patient care has always been my priority; however, any type of workplace violence disrupts quality care. When the supposedly safe spaces of healing and learning become targets, we must look at ways beyond hardening the exteriors to help prevent such violence within buildings.

For our healthcare systems, the answer may lie within our schools.

Since we lost our daughter and 16 of her classmates and staff at Marjory Stoneman Douglas High School in Parkland, Florida, six years ago, my wife and I have been advocating for enhanced school safety measures for classrooms across the nation.

Seven states have passed Alyssa's Law, named for our daughter, which requires the installation of wearable panic alarm technology in education settings. These alarms, which instantly link every classroom to emergency personnel while also providing mass communication to all staff, serve as a lifeline in times of crisis. These wearable panic alarms are not just outfitted for classrooms: they can be utilized in any workplace setting, including a healthcare system.

Despite their difference in purpose, healthcare facilities and schools share the unique properties of community spaces. Healthcare facilities are safe havens for those who need healing and rest within our community. No one should fear for their safety going to the doctor. Just as lawmakers have rethought and revised school safety requirements, they should do the same for healthcare facilities. Wearable safety technology has emerged as a formidable solution to this pressing issue.

Wearable, mobile duress badge technology is tailor-made for the unique challenges faced by healthcare workers. It is discrete, easy to use, and can be customizable for each healthcare campus. Some duress badge providers have technology that equips nurses, doctors and staff with badges that display their location and the ability to signal the level of emergency with a push of a button. They can use one badge for all campuses within a healthcare system, and they do not have to wait to get in touch with a hospital operator to “sound the alarm” or risk escalating a situation by lunging for a wall-mounted panic button.

Mobile panic alarms offer a nuanced and efficient response mechanism. Whether a minor incident or a life-threatening crisis, healthcare professionals can instantly summon help, ensuring a swifter and more coordinated response.

Texas was one of the first states to take on this alarming trend of workplace violence by passing SB240 last session, mandating facilities to establish a workplace violence prevention plan. Similar legislation is playing out in other states, becoming a nationwide movement.

I know healthcare facilities' budgets are tight these days with unprecedented rising costs of care and lower reimbursement rates. Still, through my personal journey in advocating for safety improvements in our educational institutions, I have learned one thing: you must invest in the future.

The adoption of wearable panic alarms is not just a security upgrade; it's a commitment to the well-being of those who dedicate their lives to provide healing and care. It's about protecting our community spaces. Like any other, the healthcare environment should be a sanctuary, free from the fear of violence. As Alyssa’s Law gains traction nationally, the spotlight now turns to healthcare facilities to embrace this critical technology.

Time, as we know too well, equals life. Swift action can be the difference between tragedy and survival. Investing in wearable panic alarm technology is an investment in our healthcare workforce's safety, resilience, and mental well-being. As we advocate for students to have a safe place to thrive, I am doing the same for healthcare places. The time has come to make our healthcare facilities safe.

------

Dr. Ilan Alhadeff is the father of Alyssa Alhadeff, a victim of the February 14, 2018, school shooting at Marjory Stoneman Douglas High School, and co-founder of Make Our Schools Safe, a 501(c)(3) nonprofit organization dedicated to improving school safety.

The opportunities to reach and empower underserved populations to participate in the health care workforce are limitless. Photo via Getty Images

Op-Ed: Removing barriers is critical for the future of Houston's health care workforce

guest column

Houston houses one of the most renowned medical communities in the world. However, Texas' current health care workforce shortage has severely impacted the city, with large swaths of the Gulf Coast Region deemed medically underserved. Thousands of Houstonians are impacted year after year due to the lack of access to life-saving medical care.

The obvious solution to this problem is to form a pipeline of health care workers by equipping students with the necessary skills and education to fill this gap. Sadly, many individuals who lack opportunity yet aspire to pursue a career in the health care industry face barriers related to childcare, transportation, mentorship gaps and life's unexpected circumstances.

Dwyer Workforce Development (DWD), a national health care training nonprofit, has recently expanded its footprint to Texas and has joined Houston Community College (HCC), one of the largest community colleges in the country, to provide life-changing support and create a pipeline of new health care workers, many who come from underserved areas.

Last year, our organizations launched the Dwyer Scholar Apprenticeship program, which is actively enrolling to combat the health care shortage and bring opportunities to those lacking. Working together, we are supporting apprentices each year to earn their Certified Nurse Aide (CNA) certificates, where students can choose a Phlebotomy or EKG specialization, helping our city meet the demand for one of the most essential and in-demand jobs in health care each year. Our program will help address Texas' loss of 36 percent of its CNAs over the past decade while providing gateways for highly motivated students—Dwyer Scholars—to thrive in long-term health care careers.

We know financial barriers prevent many potential health care workers from obtaining the certifications needed to enter the workforce. That's why we are bringing our innovative programs together, enabling Scholars to earn while they learn and opening doors for those who do not have the financial luxury of completing their training in a traditional educational atmosphere.

After enrollment, DWD continues to provide case management and additional financial support for pressures like housing, childcare, and transportation so Scholars don't have to put their work before their education. Scholars are placed with employers during the program, where they complete their apprenticeships and begin full-time employment following graduation.

The Texas Workforce Commission has identified apprenticeship programs as a key area for expansion to meet employer demand for skilled workers. Through our partnership, we are doing just that – and the model is proven. More than 85 percent of DWD Scholars in Maryland, where the program was established, have earned their certificates and are now employed or on track to begin their careers.

Our work doesn't end here. Over the next decade, Texas will face a shortage of 57,000 skilled nurses. Texas must continue to expand awareness and access to key workforce training programs to improve outcomes for diverse needs. Our organizations are working to vastly expand our reach, making the unattainable attainable and helping to improve the lives and health of our community.

No one's past or present should dictate their future. Everyone deserves access to health care, the ability to further their education and the chance to set and achieve life goals. The opportunities to reach and empower underserved populations to participate in the health care workforce are limitless.

------

Barb Clapp is CEO of Dwyer Workforce Development, a nonprofit that supports individuals who aspire to pursue a career in the health care industry. Christina Robinson is the executive director for work-based learning and industry partnerships at Houston Community College.

What can hospital systems do to combat climate change? A lot, according to a new report from the Center for Houston's Future. Photo via Getty Images

New report calls for Houston health care community to take action amid climate change

time for action

A new report underscores an “urgent need” for health care systems in the Houston area to combat climate change and avoid an environmental “code blue.”

“By adopting collaborative strategies and leveraging technological innovations, health care providers can play a pivotal role in safeguarding the health of Houston’s residents against the backdrop of an evolving climate landscape,” says the report, published by the Center for Houston’s Future.

Among the report’s recommendations are:

  • Advocate for policies that promote decarbonization.
  • Create eco-friendly spaces at hospitals and in low-income communities, among other places.
  • Recruit “champions” among health leaders and physicians to help battle climate change.
  • Establish academic programs to educate health care professionals and students about climate health and decarbonization.
  • Bolster research surrounding climate change.
  • Benchmark, track, and publish statistics about greenhouse gas emissions “to foster accountability and reduce environmental impacts of the health care sector.” The report notes that the U.S. health care sector emits 8.5 percent of the country’s greenhouse gases.

“By embracing collaborative strategies, acting with urgency and implementing sustainable practices, our region’s health care providers can play a pivotal role in creating a healthier, more resilient Houston,” says Brett Perlman, outgoing president and CEO of the Center for Houston’s Future. “If we work together, given all the collective wisdom, resources and innovation concentrated in our medical community, we can tackle the challenges that are confronting us.”

The report highlights the threat of climate-driven disasters in the Houston area, such as extreme heat, floods, and hurricanes. These events are likely to aggravate health issues like heatstroke, respiratory illnesses, cardiovascular diseases, and insect-borne diseases, says the report.

St. Luke’s Health, a nonprofit health care system with 16 hospitals in the Houston area and East Texas, provided funding for the report.

------

This article originally ran on EnergyCapital.

Researchers at Baylor College of Medicine’s Human Genome Sequencing Center have trained an AI assistant to explain genetic test results to patients. Photo via Getty Images

Houston researches tap into GenAI for communicating genetic test results

hi, tech

Artificial intelligence in the health care setting has a lot of potential, and one Houston institution is looking into one particular use.

Researchers at Baylor College of Medicine’s Human Genome Sequencing Center have trained an AI assistant to explain genetic test results to patients. According to findings published in the Journal of the American Medical Informatics Association (JAMIA), the team has developed generative AI to understand and interpret genetic tests. They have also tested its accuracy against Open AI’s ChatGPT 3.5.

“We created a chatbot that can provide guidance on general pharmacogenomic testing, dosage implications, and the side effects of therapeutics, and address patient concerns,” explains first author Mullai Murugan in a press release. Murugan is director of software engineering and programming at the Human Genome Sequencing Center. “We see this tool as a superpowered assistant that can increase accessibility and help both physicians and patients answer questions about genetic test results.”

The initial chatbot training specifically targeted pharmacogenomic testing for statins, meaning a patient’s potential response to cholesterol-lowering drugs, as dictated by genetics.

Murugan explains why they decided to create their own chatbot in the key publication on statin pharmacogenomics was published in May 2022, four months after the training cutoff date for ChatGPT 3.5 in January 2022. Alternatively, her team’s technology uses Retrieval Augmented Generation (RAG) and was trained on the most recent guidelines.

How did the two AI assistants compare? Four experts on cardiology and pharmacogenomics rated both chatbots based on accuracy, relevancy, risk management, and language clarity, among other factors. Though the AI scored similarly on language clarity, Baylor’s chatbot scored 85 percent in accuracy and 81 percent in relevancy compared to ChatGPT’s 58 percent in accuracy and 62 percent in relevancy when asked questions from healthcare providers.

“We are working to fine-tune the chatbot to better respond to certain questions, and we want to get feedback from real patients,” Murugan says. “Based on this study, it is very clear that there is a lot of potential here.” Nonetheless, Murugan emphasized that there is much work still to be done before the program is ready for clinical applications. That includes training the chatbot to explain results in the language used by genetic counselors. Funds from the NIH’s All of Us Research Program helped to make the research possible.

Ayse McCracken, founder of Ignite Healthcare Network, joins the Houston Innovators Podcast to discuss how she's growing her impact on female health tech founders. Photo via LinkedIn

Houston health tech leader to expand accelerator to continue connecting female founders

HOUSTON INNOVATORS PODCAST EPISODE 203

With a decades-long career in health care, Ayse McCracken's most recent professional chapter has been laser focused on finding, supporting, and accelerating female-founded startups in health tech with her nonprofit, Ignite Healthcare Network.

Originally founded in 2017 as a pitch competition, Ignite has evolved to become an active and integral program for female health tech entrepreneurs. Ninety-one founders have graduated from Ignite and gone on to raise over $550 million in funding for their ventures. Currently, Ignite has 19 women in its 2023 cohort, which concludes November 9 with the annual Fire Pitch competition.

"Having an impact in the health care industry and finding solutions is important to me," McCracken says of her passion for Ignite on this week's episode of the Houston Innovators Podcast. "The second aspect of that is there are so many women in health care, and yet you don't see them in leadership roles."

With Ignite, McCracken is actively seeking out these potential female leaders, and giving them the support — through mentorship, programming, and networking opportunities — they need to grow their business.

Each year, McCracken explains, she's pushing the envelope with what she can accomplish with Ignite. This year, she hosted a new event in Dallas to reach female founders there, and coming soon, Ignite will launch a platform that will extend its relationship with its founders and keep them looped in with potential customers, mentors, investors, and more.

"We're in the process of building our own platform that continues to connect our ecosystem so that we're not just an episode in the journey of an entrepreneur, but that we have the ability to help them along their path," McCracken says. "That path is a rollercoaster for a variety of reasons — whether it's gender or market related — and if we help to provide a community that can provide support for companies that have promise, our goal is to, over time, triple the money that female entrepreneurs are getting."

But McCracken says she wants Ignite to do more than just find investors for her network of founders.

"Success to me isn't just getting people an early stage investment," she explains. "Success to me is getting companies that actually commercialize, get their products in the market, and that they are actually making an impact on health wellbeing, patients, and so forth."

McCracken shares more about the future of Ignite on the podcast. Listen to the interview here — or wherever you stream your podcasts — and subscribe for weekly episodes.

As the health care industry continues to evolve, experience management technology will play an increasingly important role in addressing health equity gaps and improving the health and well-being of patients across the globe. Photo via Getty Images

Houston expert: How technology can be used to bridge the health equity gap

guest column

Progressively over the last decade, the health care industry has become increasingly aware of the role that social determinants of health play in the health outcomes of patients.

Social determinants of health, or SDOH, are the conditions in which people are born, grow, live, work, and age, and they have a significant impact on a person's health and well-being. Examples of SDOH include income, education level, housing, and access to healthy food.

One of the key challenges facing health care organizations and providers is how to address health equity gaps, which are the differences in health outcomes between different populations. Health equity gaps are often caused by social determinants of health, and they can be particularly pronounced among vulnerable populations such as low-income communities, racial and ethnic minorities, and those living in rural areas.

Experience management technology has emerged as a powerful tool for addressing these equity gaps. This technology uses feedback, behaviors, and other relevant SDOH data in order to understand the unique needs of different populations and develop targeted interventions to improve their health outcomes.

One of the key ways that experience management technology can help decrease health equity gaps is by segmenting populations by social determinants of health. By collecting data on patients' demographics, such as their age, race, income, and education level, health care organizations can gain a better understanding of the SDOH that are most relevant to each population. This information can be used to develop personalized actions that address the specific needs of each population, rather than relying on a one-size-fits-all approach.

For example, health care organizations could use experience management technology to gather feedback from patients on their access to healthy food. By segmenting the patient population by zip code, health care organizations could identify patients in rural areas who do not have easy access to quality care facilities and providers. These patients could then be targeted with interventions such as transportation assistance programs or care coordination programs, which could help address their specific needs.

In addition to segmenting populations by social determinants of health, experience management technology can also help health care organizations gather insights into patient behaviors. By integrating data on patients' health behaviors, such as adherence to treatment or missed appointments, health care organizations can develop targeted interventions that encourage healthy behaviors.

For example, health care providers could use experience management technology to collect data on patients' treatment habits. Patients who report low adherence to treatment could be targeted with interventions such as treatment education programs or care coaching, which could help them develop healthier habits over time.

Finally, experience management technology can help health care organizations gain insight into their patient’s end to end journey. By integrating data from multiple sources, such as electronic health records, patient feedback, and social determinants of health data, health care organizations can develop a more comprehensive understanding of patients' health needs and brand expectations. This unified illustration allows health care organizations to improve business outcomes such as lower readmission rates, and create loyal patients that will refer their friends and family in the most important and sensitive moments in their lives.

In conclusion, experience management technology has emerged as a powerful tool for addressing health equity gaps by segmenting populations by social determinants of health, understanding and acting on their unique needs through feedback, behaviors, and dynamic integrations. By leveraging this technology, health care organizations can develop unique solutions that improve the health outcomes of vulnerable populations, such as low-income communities, racial and ethnic minorities, and those living in rural areas.

As the health care industry continues to evolve, experience management technology will play an increasingly important role in addressing health equity gaps and improving the health and well-being of patients across the globe.

------

Ariel Jones is the head of health care provider solution strategy for Qualtrics XM, an American Experience Management company providing software solutions for customer and employee experience.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Texas tops ranking of best state for investors in new report

by the numbers

Texas ranks third on a new list of the best states for investors and startups.

Investment platform BrokerChooser weighed five factors to come up with its ranking:

  • 2024 Google search volume for terms related to investing
  • Number of investors
  • Number of businesses receiving investments in 2024
  • Total amount of capital invested in businesses in 2024
  • Percentage change in amount of investment from 2019 to 2024

Based on those figures, provided mostly by Crunchbase, Texas sits at No. 3 on the list, behind No. 1 California and No. 2 New York.

Especially noteworthy for Texas is its investment total for 2024: more than $164.5 billion. From 2019 to 2024, the state saw a 440 percent jump in business investments, according to BrokerChooser. The same percentages are 204 percent for California and 396 percent for New York.

“There is definitely development and diversification in the American investment landscape, with impressive growth in areas that used to fly under the radar,” says Adam Nasli, head analyst at BrokerChooser.

According to Crunchbase, funding for Texas startups is off to a strong start in 2025. In the first three months of this year, venture capital investors poured nearly $2.9 billion into Lone Star State companies, Crunchbase data shows. Crunchbase attributes that healthy dollar amount to “enthusiasm around cybersecurity, defense tech, robotics, and de-extincting mammoths.”

During the first quarter of this year, roughly two-thirds of VC funding in Texas went to just five companies, says Crunchbase. Those companies are Austin-based Apptronik, Austin-based Colossal Biosciences, Dallas-based Island, Austin-based NinjaOne, and Austin-based Saronic.

Autonomous truck company rolls out driverless Houston-Dallas route

up and running

Houston is helping drive the evolution of self-driving freight trucks.

In October, Aurora opened a more than 90,000-square-foot terminal at a Fallbrook Drive logistics hub in northwest Houston to support the launch of its first “lane” for driverless trucks—a Houston-to-Dallas route on the Interstate 45 corridor. Aurora opened its Dallas-area terminal in April and the company began regular driverless customer deliveries between the two Texas cities on April 27.

Close to half of all truck freight in Texas moves along I-45 between Houston and Dallas.

“Now, we are the first company to successfully and safely operate a commercial driverless trucking service on public roads. Riding in the back seat for our inaugural trip was an honor of a lifetime – the Aurora Driver performed perfectly and it’s a moment I’ll never forget,” Chris Urmson, CEO and co-founder of Pittsburgh-based Aurora, said in a news release.

Aurora produces software that controls autonomous vehicles and is known for its flagship product, the Aurora Driver. The software is installed in Volvo and Paccar trucks, the latter of which includes brands like Kenworth and Peterbilt.

Aurora previously hauled more than 75 loads per week under the supervision of vehicle operators from Houston to Dallas and Fort Worth to El Paso for customers in its pilot project, including FedEx, Uber Freight and Werner. To date, it has completed over 1,200 miles without a driver.

The company launched its new Houston to Dallas route with customers Uber Freight and Hirschbach Motor Lines, which ran supervised commercial pilots with Aurora.

“Transforming an old school industry like trucking is never easy, but we can’t ignore the safety and efficiency benefits this technology can deliver. Autonomous trucks aren’t just going to help grow our business – they’re also going to give our drivers better lives by handling the lengthier and less desirable routes,” Richard Stocking, CEO of Hirschbach Motor Lines, added in the statement.

The company plans to expand its service to El Paso and Phoenix by the end of 2025.

“These new, autonomous semis on the I-45 corridor will efficiently move products, create jobs, and help make our roadways safer,” Gov. Greg Abbott added in the release. “Texas offers businesses the freedom to succeed, and the Aurora Driver will further spur economic growth and job creation in Texas. Together through innovation, we will build a stronger, more prosperous Texas for generations.”

In July, Aurora said it raised $820 million in capital to fuel its growth—growth that’s being accompanied by scrutiny.

In light of recent controversies surrounding self-driving vehicles, the International Brotherhood of Teamsters, whose union members include over-the-road truckers, recently sent a letter to Lt. Gov. Dan Patrick calling for a ban on autonomous vehicles in Texas.

“The Teamsters believe that a human operator is needed in every vehicle—and that goes beyond partisan politics,” the letter states. “State legislators have a solemn duty in this matter to keep dangerous autonomous vehicles off our streets and keep Texans safe. Autonomous vehicles are not ready for prime time, and we urge you to act before someone in our community gets killed.”

Houston cell therapy company launches second-phase clinical trial

fighting cancer

A Houston cell therapy company has dosed its first patient in a Phase 2 clinical trial. March Biosciences is testing the efficacy of MB-105, a CD5-targeted CAR-T cell therapy for patients with relapsed or refractory CD5-positive T-cell lymphoma.

Last year, InnovationMap reported that March Biosciences had closed its series A with a $28.4 million raise. Now, the company, co-founded by Sarah Hein, Max Mamonkin and Malcolm Brenner, is ready to enroll a total of 46 patients in its study of people with difficult-to-treat cancer.

The trial will be conducted at cancer centers around the United States, but the first dose took place locally, at The University of Texas MD Anderson Cancer Center. Dr. Swaminathan P. Iyer, a professor in the department of lymphoma/myeloma at MD Anderson, is leading the trial.

“This represents a significant milestone in advancing MB-105 as a potential treatment option for patients with T-cell lymphoma who currently face extremely limited therapeutic choices,” Hein, who serves as CEO, says. “CAR-T therapies have revolutionized the treatment of B-cell lymphomas and leukemias but have not successfully addressed the rarer T-cell lymphomas and leukemias. We are optimistic that this larger trial will further validate MB-105's potential to address the critical unmet needs of these patients and look forward to reporting our first clinical readouts.”

The Phase 1 trial showed promise for MB-105 in terms of both safety and efficacy. That means that potentially concerning side effects, including neurological events and cytokine release above grade 3, were not observed. Those results were published last year, noting lasting remissions.

In January 2025, MB-105 won an orphan drug designation from the FDA. That results in seven years of market exclusivity if the drug is approved, as well as development incentives along the way.

The trial is enrolling its single-arm, two-stage study on ClinicalTrials.gov. For patients with stubborn blood cancers, the drug is providing new hope.